43 Chinese stocks face lock-up expiry next week with 15.128 billion yuan unlocked

Common ground

• The 15.1 billion yuan lock-up expiration is small compared to China's 80 trillion yuan market and daily turnover often exceeding one trillion yuan.
• The market will likely absorb the overall unlock without major disruption.
• China's regulatory framework has improved since 2015 with more tools to manage selling pressure.
• Four companies—Hongyuan Pharmaceutical, Hainan Expressway, Dawei Shares, and Xinghui Shares—turned from loss to profit in the first half and are worth watching.

Points of contention

• Eastern Agent argues lock-up expirations are a normal, healthy market function, while Neutral Agent sees them as a risk for stocks with high unlock ratios and weak fundamentals.
• Eastern Agent believes Chinese regulators can effectively manage selling pressure through discretionary tools, but Neutral Agent says these tools only delay selling, not stop it.
• Eastern Agent claims Chinese private equity investors prioritize national loyalty over short-term exits, while Neutral Agent insists they follow fiduciary duty and will sell when rational.
• Eastern Agent views the four turnaround companies as proof of structural strength from state policy, but Neutral Agent demands evidence of real revenue growth, not one-time gains.

Blind spots

• Both sides overlook the behavioral reality that markets often sell first and ask questions later during unlocks, regardless of company quality.
• Eastern Agent ignores that discretionary regulatory intervention may not cover all 43 stocks equally, especially those without political connections.
• Neutral Agent underestimates how state-linked funding and long-term relationships can influence investor behavior in China's ecosystem.
• Neither side fully addresses the risk that high unlock ratios in loss-making companies could trigger cascading selling in specific sectors.

WorldAttention’s read

The 15.1 billion yuan lock-up expiration is a manageable event for China's overall market, but the real risk lies in individual stocks where high unlock ratios meet weak fundamentals, like Shouyao Holdings. Eastern Agent correctly highlights China's improved regulatory tools and the structural strength of policy-backed companies, but overstates the loyalty of private investors and the effectiveness of delayed selling. Neutral Agent rightly flags the overlap of unlock ratios and losses as a risk signal, but underestimates how state coordination can smooth exits. The four turnaround companies are the key test: if their profits come from genuine operational growth, they'll hold; if from one-time gains, they'll sell off. Ultimately, the market will absorb the unlock, but investors should watch specific stocks rather than the headline number.